
UnicoCell — Investor Relations & Filings
UnicoCell Biomed Co., Ltd. specializes in regenerative medicine, focusing on the research, development, and clinical application of stem cell technologies. The company’s operations are centered on three primary axes: the development of novel stem cell therapeutics, the production of stem cell-derived exosomes, and the provision of cell manufacturing and Contract Development and Manufacturing Organization (CDMO) services. Its lead candidate, ELIXCYTE, is an adipose-derived stem cell therapy undergoing Phase 3 clinical trials for indications such as knee osteoarthritis and chronic kidney disease. Additionally, the company maintains an allogeneic stem cell bank and provides autologous adipose-derived stem cell therapy services. Utilizing patented manufacturing processes and proprietary technology, UnicoCell offers integrated solutions from research to large-scale production to address unmet medical needs in the regenerative therapy sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 本公司脂肪幹細胞新藥ELIXCYTE治療膝骨關節炎 (Knee Osteoarthritis)之人體臨床試驗,向衛生福利部 提出申請臨床試驗設計變更。 | 2026-05-29 | Chinese | |
| 功能性委員會成員 | 2026-05-21 | Chinese | |
| 功能性委員會成員 | 2026-05-21 | Chinese | |
| 公告本公司董事會委任薪資報酬委員會委員 | 2026-05-20 | Chinese | |
| 公告本公司審計委員會委員異動 | 2026-05-20 | Chinese | |
| 公告本公司董事會選任董事長 | 2026-05-20 | Chinese |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47889775 | 本公司脂肪幹細胞新藥ELIXCYTE治療膝骨關節炎 (Knee Osteoarthritis)之人體臨床試驗,向衛生福利部 提出申請臨床試驗設計變更。 | 2026-05-29 | Chinese | ||
| 46707409 | 功能性委員會成員 | 2026-05-21 | Chinese | ||
| 46707411 | 功能性委員會成員 | 2026-05-21 | Chinese | ||
| 46586514 | 公告本公司董事會委任薪資報酬委員會委員 | 2026-05-20 | Chinese | ||
| 46586515 | 公告本公司審計委員會委員異動 | 2026-05-20 | Chinese | ||
| 46586516 | 公告本公司董事會選任董事長 | 2026-05-20 | Chinese | ||
| 46586518 | 公告本公司115年股東常會通過解除董事競業禁止之限制 | 2026-05-20 | Chinese | ||
| 46584900 | 公告本公司115年股東常會重要決議事項 | 2026-05-20 | Chinese | ||
| 46584942 | 公告本公司115年股東常會董事改選當選名單(含獨立董事) | 2026-05-20 | Chinese | ||
| 46577281 | 公司治理組織架構 | 2026-05-20 | Chinese | ||
| 45809303 | 115年第1季財務報告書 — 202601_6794_AI2.pdf | 2026-05-12 | Chinese | ||
| 45746236 | 115年第1季權益變動表 | 2026-05-11 | Chinese | ||
| 45741522 | 115年第1季現金流量表 | 2026-05-11 | Chinese | ||
| 45741333 | 115年第1季綜合損益表 | 2026-05-11 | Chinese | ||
| 45740917 | 115年第1季資產負債表 | 2026-05-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biovica International B
Develops blood-based biomarker assays for cancer therapy mo…
|
BIOVIC | SE | Professional, scientific and te… |
|
Boji Medical Technology Co., Ltd.
A CRO providing full-service pharmaceutical and medical dev…
|
300404 | CN | Professional, scientific and te… |
|
Bonus BioGroup Ltd.
A clinical-stage biotech firm developing cell therapy and t…
|
BONS | IL | Professional, scientific and te… |
|
BPH GLOBAL LTD
Biotech firm focused on plant-based health products and fun…
|
BP8 | AU | Professional, scientific and te… |
|
BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical,…
|
BNN | DE | Professional, scientific and te… |
|
BriaCell Therapeutics Corp.
Clinical-stage immuno-oncology company developing cellular …
|
BCTX | CA | Professional, scientific and te… |
|
Bright Minds Biosciences Inc.
Developing innovative serotonin-based drugs for neurologica…
|
DRUG | CA | Professional, scientific and te… |
|
BRIM
Develops therapies for ophthalmology and degenerative disea…
|
6885 | TW | Professional, scientific and te… |
|
BSF ENTERPRISE PLC
Develops cell-based solutions for cultivated meat, leather,…
|
BSFA | GB | Professional, scientific and te… |
|
BullFrog AI Holdings, Inc.
A technology company applying AI and machine learning to dr…
|
BFRG | US | Professional, scientific and te… |
UnicoCell via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52633/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52633 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52633 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52633 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52633}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for UnicoCell (id: 52633)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.